Cargando…

Enhanced cell survival and therapeutic benefits of IL-10-expressing multipotent mesenchymal stromal cells for muscular dystrophy

BACKGROUND: Multipotent mesenchymal stromal cells (MSCs) are potentially therapeutic for muscle disease because they can accumulate at the sites of injury and act as immunosuppressants. MSCs are attractive candidates for cell-based strategies that target diseases with chronic inflammation, such as D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nitahara-Kasahara, Yuko, Kuraoka, Mutsuki, Oda, Yuki, Hayashita-Kinoh, Hiromi, Takeda, Shin’ichi, Okada, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860619/ https://www.ncbi.nlm.nih.gov/pubmed/33541428 http://dx.doi.org/10.1186/s13287-021-02168-1

Ejemplares similares

Improved transduction of canine X-linked muscular dystrophy with rAAV9-microdystrophin via multipotent MSC pretreatment
por: Hayashita-Kinoh, Hiromi, et al.
Publicado: (2020)

Dental pulp stem cells can improve muscle dysfunction in animal models of Duchenne muscular dystrophy
por: Nitahara-Kasahara, Yuko, et al.
Publicado: (2021)

Inflammatory predisposition predicts disease phenotypes in muscular dystrophy
por: Nitahara-Kasahara, Yuko, et al.
Publicado: (2016)

Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9
por: Okada, Hironori, et al.
Publicado: (2013)

Development of outcome measures according to dystrophic phenotypes in canine X-linked muscular dystrophy in Japan
por: Kuraoka, Mutsuki, et al.
Publicado: (2021)

Initial Pulmonary Respiration Causes Massive Diaphragm Damage and Hyper-CKemia in Duchenne Muscular Dystrophy Dog
por: Nakamura, Akinori, et al.
Publicado: (2013)

Immunomodulatory amnion-derived mesenchymal stromal cells preserve muscle function in a mouse model of Duchenne muscular dystrophy
por: Nitahara-Kasahara, Yuko, et al.
Publicado: (2023)

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
por: Miskew Nichols, Bailey, et al.
Publicado: (2016)

Accelerometric outcomes of motor function related to clinical evaluations and muscle involvement in dystrophic dogs
por: Kuraoka, Mutsuki, et al.
Publicado: (2018)

Characterization of a novel microRNA, miR-188, elevated in serum of muscular dystrophy dog model
por: Shibasaki, Hiroyuki, et al.
Publicado: (2019)

rAAV8 and rAAV9-Mediated Long-Term Muscle Transduction with Tacrolimus (FK506) in Non-Human Primates
por: Ishii, Akiko, et al.
Publicado: (2020)

Current Challenges and Future Directions in Recombinant AAV-Mediated Gene Therapy of Duchenne Muscular Dystrophy
por: Okada, Takashi, et al.
Publicado: (2013)

Exon-Skipping in Duchenne Muscular Dystrophy
por: Takeda, Shin’ichi, et al.
Publicado: (2021)

Progress in muscular dystrophy research with special emphasis on gene therapy
por: SUGITA, Hideo, et al.
Publicado: (2010)

Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors
por: Miyatake, Shouta, et al.
Publicado: (2016)

Mammalian Models of Duchenne Muscular Dystrophy: Pathological Characteristics and Therapeutic Applications
por: Nakamura, Akinori, et al.
Publicado: (2011)

Restoring Dystrophin Expression in Duchenne Muscular Dystrophy: Current Status of Therapeutic Approaches
por: Shimizu-Motohashi, Yuko, et al.
Publicado: (2019)

A phase I study of TAS‐205 in patients with Duchenne muscular dystrophy
por: Takeshita, Eri, et al.
Publicado: (2018)

Stromal cell-derived factors in Duchenne muscular dystrophy
por: Abdel-Salam, E., et al.
Publicado: (2010)

Characteristics of Japanese Patients with Becker Muscular Dystrophy and Intermediate Muscular Dystrophy in a Japanese National Registry of Muscular Dystrophy (Remudy): Heterogeneity and Clinical Variation
por: Mori-Yoshimura, Madoka, et al.
Publicado: (2018)

Trends in steroid therapy for Duchenne muscular dystrophy in Japan
por: Takeuchi, Fumi, et al.
Publicado: (2016)

Comparison of Experimental Protocols of Physical Exercise for mdx Mice and Duchenne Muscular Dystrophy Patients
por: Hyzewicz, Janek, et al.
Publicado: (2015)

Characteristics of Japanese Duchenne and Becker muscular dystrophy patients in a novel Japanese national registry of muscular dystrophy (Remudy)
por: Nakamura, Harumasa, et al.
Publicado: (2013)

Identification of Muscle-Specific MicroRNAs in Serum of Muscular Dystrophy Animal Models: Promising Novel Blood-Based Markers for Muscular Dystrophy
por: Mizuno, Hideya, et al.
Publicado: (2011)

Induction of Pluripotent Stem Cells from a Manifesting Carrier of Duchenne Muscular Dystrophy and Characterization of Their X-Inactivation Status
por: Miyagoe-Suzuki, Yuko, et al.
Publicado: (2017)

Large-scale purification of functional AAV particles packaging the full genome using short-term ultracentrifugation with a zonal rotor
por: Wada, Mikako, et al.
Publicado: (2023)

Mitochondria mediate cell membrane repair and contribute to Duchenne muscular dystrophy
por: Vila, Maria C, et al.
Publicado: (2017)

Modelling Duchenne muscular dystrophy in MYOD1-converted urine-derived cells treated with 3-deazaneplanocin A hydrochloride
por: Takizawa, Hotake, et al.
Publicado: (2019)

Meniscus Regeneration With Multipotent Stromal Cell Therapies
por: Zhou, Yun-Feng, et al.
Publicado: (2022)

Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy
por: Taniguchi-Ikeda, Mariko, et al.
Publicado: (2011)

Identification of a Candidate Proteomic Signature to Discriminate Multipotent and Non-Multipotent Stromal Cells
por: Rosu-Myles, Michael, et al.
Publicado: (2012)

Publisher Correction: Modelling Duchenne muscular dystrophy in MYOD1-converted urine-derived cells treated with 3-deazaneplanocin A hydrochloride
por: Takizawa, Hotake, et al.
Publicado: (2020)

Dental-Pulp Stem Cells as a Therapeutic Strategy for Ischemic Stroke
por: Nito, Chikako, et al.
Publicado: (2022)

Prednisolone improves walking in Japanese Duchenne muscular dystrophy patients
por: Takeuchi, Fumi, et al.
Publicado: (2013)

Regulation of Immunity via Multipotent Mesenchymal Stromal Cells
por: Rubtsov, Y. P., et al.
Publicado: (2012)

Adult multipotent stromal cell cryopreservation: Pluses and pitfalls
por: Duan, Wei, et al.
Publicado: (2017)

Editorial: Multipotent stromal cells and microenvironment of the tissue healing
por: Lotfy, Ahmed, et al.
Publicado: (2023)

Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMD(J))
por: Fukushima, Kazuhiro, et al.
Publicado: (2007)

Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases
por: Tsoumpra, Maria K., et al.
Publicado: (2019)

Multipotent Mesenchymal Stromal Cells: Possible Culprits in Solid Tumors?
por: Johann, Pascal David, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1e1fh4hmem92smiru1gib7boue